Mid-Atlantic Epilepsy and Sleep Center   Report issue

Academic/Hospital Phase 2 Phase 3 Phase 4
Founded: Bethesda MD United States (2003)

Organization Overview

First Clinical Trial
2005
NCT01463033
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2017

Timeline

NOW
  • Now

Alternative names

Mid-Atlantic Epilepsy and Sleep center | Mid-Atlantic Epilepsy and Sleep Center | Mid-Atlantic Epilepsy and Sleep Center, LLC | Pavel Klein